Paychex Inc. (0KGE)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 112.88 |
|---|---|
| 52-week range | 83.05 – 131.07 |
| Return, 1 month / 3 months | −2.1% / +3.0% |
| Return, 1 year / 3 years | −7.8% / +7.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 60 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 0.22M USD |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Paychex is a provider of payroll and human resources services based in Rochester, New York. It handles payroll processing and payroll tax administration for employers, and it also offers employee benefits administration, retirement plan services and related human resources support. Its customers are mainly small and mid-sized businesses that rely on it to manage routine payroll and staff administration tasks. The company operates through a network of local branches and serves clients across the United States.
On this site Paychex Inc. appears as a stock on the London Exchange (UK), code 0KGE, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Paychex Inc. (0KGE) trades on the London Exchange in UK. It last closed at USD 112.88 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,217 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.8% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.4% | ||
| From 52-week high | -11.2% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | 24.8% | ||
| 12-month return, skipping the last month | -5.7% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.22M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 82 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +6.9% |
|---|---|
| 1 month | −2.1% |
| 3 months | +3.0% |
| 6 months | +24.8% |
| 1 year | −7.8% |
| 3 years | +7.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 114.20 / 102.21 |
|---|---|
| Golden / death cross (60 days) | Golden, 59 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jul 2026 | USD 1.1900 |
| 12 May 2026 | USD 1.1900 |
| 27 Jan 2026 | USD 1.0800 |
| 6 Nov 2025 | USD 1.0800 |
| 18 Jul 2025 | USD 1.0800 |
| 9 May 2025 | USD 1.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.